Here are five quick facts:
1. Tenet’s short term standard deviation is valued at 14.46.
2. The company’s target price could reach $85 on the higher end.
3. On the lower end, analysts predict the target price could fall to $36.
4. The shares hold a recommendation consensus of “buy.”
5. In the last four weeks, the shares fell 9.2 percent.
More articles on surgery centers:
AmSurg shares fall 1.6% — 5 quick facts
Surgery Partners Q3 revenue up 214% — 10 key points
Tenet, Baylor Scott & White Health partner on 5 Texas hospitals — 5 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.